Case Study

The genesis of the Abaxis Piccolo technology began with NASA, where scientists sought to develop and manufacture a small ...

Home October 03, 2006
Home
Technology

SmartPumps are tourniquet systems offering OR connectivity, superior performance, exceptional battery life and intuitive ...

Home October 03, 2006
Home
News

A retrospective study at Northwestern University Feinberg School of Medicine, Chicago, showed that dialysis patients who ...

Home October 02, 2006
Home
News

A new study in Denmark links healthy teeth and gums with heart health. Theheart.org reports that Danish investigators ...

Home October 02, 2006
Home
News

Catheters of all types as well as other intravascular devices (IVDs) that allow access to the bloodstream are potential ...

Home October 02, 2006
Home
News

Public confidence in the FDA is low and big changes may be in order to fix the system for approving and regulating drugs ...

Home October 02, 2006
Home
News

ATS Medical, Inc., a manufacturer of cardiac surgery products and services focused, has announced completion of its ...

Home October 01, 2006
Home
News

Americans Andrew Z. Fire and Craig C. Mello have won the Nobel Prize in medicine Monday for their discover of “RNA ...

Home October 01, 2006
Home
News

FDA and Duke Clinical Research Institute will be working to develop a new generation of tools that enable early identification of potential cardiac side effects of drugs and devices. The agency will use a database comprising more than 200,000 ECGs to conduct the research.

Home October 01, 2006
Home
News

A new, private research group, the Center for Medical Technology Policy is being formed to provide healthcare clinicians ...

Home October 01, 2006
Home
News

Researchers at the Technion Institute, Israel, are developing a new method that may prevent heart attacks following ...

Home October 01, 2006
Home
News

Expanding their existing strategic collaboration for atherosclerotic plaque analysis, FoxHollow Technologies and Merck & ...

Home September 28, 2006
Home
News

Administering a cholesterol-lowering drug prior to heart bypass surgery or surgical repair of a faulty heart valve may reduce the occurrence of atrial fibrillation, a common heart rhythm disturbance triggered by these surgeries. The research was published in “Circulation: Journal of the American Heart Association.”

Home September 28, 2006
Home
News

Final recommendations issued Sept. 28 from the Heart Rhythm Society are aimed at providing heart patients with clearer ...

Home September 28, 2006
Home
News

Zargis Medical Corp., a spin-off from Siemens Corporate Research and a majority-owned subsidiary of Speedus Corp., has ...

Home September 28, 2006
Home
Subscribe Now